1. Jiang, Haiping, Yu, Dingyi, Yang, Penghui, Lu, Xiaoyan, Fan, Xiaohui. . Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing. In Clinical and translational medicine, 12, e730. doi:10.1002/ctm2.730. https://pubmed.ncbi.nlm.nih.gov/35184420/
2. Bexte, Tobias, Alzubi, Jamal, Reindl, Lisa Marie, Cathomen, Toni, Ullrich, Evelyn. 2022. CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma. In Oncoimmunology, 11, 2081415. doi:10.1080/2162402X.2022.2081415. https://pubmed.ncbi.nlm.nih.gov/35694192/
3. Mac Donald, Alice, Guipouy, Delphine, Lemieux, William, Béland, Kathie, Haddad, Elie. 2023. KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors. In Frontiers in immunology, 14, 1231916. doi:10.3389/fimmu.2023.1231916. https://pubmed.ncbi.nlm.nih.gov/37675109/
4. Shreeve, Norman, Depierreux, Delphine, Hawkes, Delia, Sharkey, Andrew M, Colucci, Francesco. 2021. The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice. In Immunity, 54, 1231-1244.e4. doi:10.1016/j.immuni.2021.03.021. https://pubmed.ncbi.nlm.nih.gov/33887202/
5. Hussein, Brwa Ali, Kristenson, Linnea, Pesce, Silvia, Bernson, Elin, Thorén, Fredrik B. . NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells. In Journal for immunotherapy of cancer, 11, . doi:10.1136/jitc-2023-007202. https://pubmed.ncbi.nlm.nih.gov/37648262/
智鼠故事 
